The corpus has been raised from seven large institutional investors, including an unnamed US-based asset manager that has $4 trillion in under management and a 300-year old European company.
Private equity fund India Life Sciences Fund II has raised Rs 865 crore in its second fund to tap Indian mid-market companies in healthcare services, pharmaceuticals and medical technology space, as reported by Economic Times.
The corpus has been raised from seven large institutional investors, including an unnamed US-based asset manager that has $4 trillion in under management and a 300-year old European company.
"Fundraising was not a walk in the park. Focus of LPs was not only on the investments and returns generated from exits, but also on value addition in terms of specific actions by the team,” Hari Buggana, MD, Hyderabad-based InvAscent told ET.
Business Opportunities
Our Group Sites
Popular Cities
